Cardinal Partners
Since 1996, Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies as early/growth stage partners, believing waves of healthcare reform create opportunities to deliver more care to more people for less money.
Check Size—
StagesSeed, Early, Growth
LocationUS
Data quality55good
Investment thesis
Since 1996, Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies as early/growth stage partners, believing waves of healthcare reform create opportunities to deliver more care to more people for less money.
90 confidence · stated by fund
What sets Cardinal Partners apart
- 25+ year track record (1996-present)
- Positioned as founding/first institutional investor in portfolio companies
- 25+ IPO participations with $15B+ cumulative portfolio market valuation
- Deep networks in academic, clinical, and industry communities
Investment profile
- Stages
- Seed, Early, Growth
- Sectors
- Healthcare, Life sciences, Healthcare IT, Biopharmaceuticals
- Cold inbound
- Accepted
Frequently asked questions
- What does Cardinal Partners invest in?
- Cardinal Partners is a seed, early, growth stage Healthcare, Life sciences, Healthcare IT, Biopharmaceuticals investor, primarily investing in US. Their thesis: Since 1996, Cardinal Partners invests in disruptive healthcare technology-enabled services and life sciences companies as early/growth stage partners, believing waves of healthcare reform create opportunities to deliver more care to more people for less money.
- Is Cardinal Partners actively deploying capital?
- Cardinal Partners is actively deploying capital. What we observed: Active portfolio with recent exits (Sapphire acquired Sep 2021, Athena acquired Feb 2022) and ongoing portfolio companies listed as active
- What makes Cardinal Partners different from other funds?
- Cardinal Partners stands out on 4 points: 25+ year track record (1996-present); Positioned as founding/first institutional investor in portfolio companies; 25+ IPO participations with $15B+ cumulative portfolio market valuation; Deep networks in academic, clinical, and industry communities.
- What other funds are similar to Cardinal Partners?
- Funds with overlapping stage and sector focus include Red Bike Capital, Wireframe Ventures, Sequoia Capital. See the full list below, or use DryPowder's AI fund matching to rank all tracked funds by fit with your specific startup.
- How do I reach out to Cardinal Partners?
- Cardinal Partners accepts cold outreach, so you don't need a warm introduction to get a first read. Check their website for a submission form or contact address. Use DryPowder's AI fund matching to see how your startup aligns with Cardinal Partners's thesis and focus areas (Healthcare, Life sciences, Healthcare IT, Biopharmaceuticals) — it returns a fit score and specific talking points for your outreach.